These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1295618)

  • 1. Specific cytokine regulators and their therapeutic potentials--an overview.
    Kashiwagi H; Suzuki H
    Intern Med; 1992 Nov; 31(11):1245-9. PubMed ID: 1295618
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine networks: do we understand them well enough to facilitate clinical benefits?
    Feldmann M
    Eur Cytokine Netw; 1991; 2(1):5-9. PubMed ID: 1831391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines as mediators in the pathogenesis of septic shock.
    Dinarello CA
    Curr Top Microbiol Immunol; 1996; 216():133-65. PubMed ID: 8791739
    [No Abstract]   [Full Text] [Related]  

  • 4. Endotoxin, sepsis, and the primrose path.
    O'Reilly M; Newcomb DE; Remick D
    Shock; 1999 Dec; 12(6):411-20. PubMed ID: 10588508
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokines and natural regulators of cytokines.
    Bendtzen K
    Immunol Lett; 1994 Dec; 43(1-2):111-23. PubMed ID: 7737681
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interleukin-1 receptor antagonist: a new therapeutic agent in the treatment of sepsis syndrome].
    Boermeester MA; van Leeuwen PA; Schneider AJ; Houdijk AP; Ferwerda CC; Wesdorp RI
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):337-42. PubMed ID: 7679779
    [No Abstract]   [Full Text] [Related]  

  • 7. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.
    Dinarello CA
    Chest; 1997 Dec; 112(6 Suppl):321S-329S. PubMed ID: 9400897
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.
    Zeni F; Freeman B; Natanson C
    Crit Care Med; 1997 Jul; 25(7):1095-100. PubMed ID: 9233726
    [No Abstract]   [Full Text] [Related]  

  • 9. The biological role of naturally-occurring cytokine inhibitors.
    Arend WP; Malyak M; Bigler CF; Smith MF; Janson RW
    Br J Rheumatol; 1991; 30 Suppl 2():49-52. PubMed ID: 1847086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cytokine responses in sepsis.
    Lowry SF; Moldawer LL
    Ann N Y Acad Sci; 1993 Jun; 685():471-82. PubMed ID: 8363256
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-1 and its inhibitors: implications for disease biology and therapy.
    Estrov Z; Kurzrock R; Talpaz M
    Cancer Treat Res; 1995; 80():51-82. PubMed ID: 8821574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Pinchera A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):446-8. PubMed ID: 8636246
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.
    Fischer E; Marano MA; Van Zee KJ; Rock CS; Hawes AS; Thompson WA; DeForge L; Kenney JS; Remick DG; Bloedow DC
    J Clin Invest; 1992 May; 89(5):1551-7. PubMed ID: 1533231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cornell Medical College scientists unlock mechanism underlying septic shock.
    Mil Med; 1992 Oct; 157(10):A21. PubMed ID: 1333576
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticytokine strategies for the treatment of septic shock: relevance of animal models.
    Heumann D; Glauser MP
    Curr Top Microbiol Immunol; 1996; 216():299-311. PubMed ID: 8791746
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome.
    Dinarello CA; Gelfand JA; Wolff SM
    JAMA; 1993 Apr; 269(14):1829-35. PubMed ID: 8459516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis therapy trials. Continued disappointment or reason for hope?
    Abraham E; Raffin TA
    JAMA; 1994 Jun; 271(23):1876-8. PubMed ID: 8196148
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of cytokines in sepsis.
    Hack CE; Aarden LA; Thijs LG
    Adv Immunol; 1997; 66():101-95. PubMed ID: 9328641
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson RC
    Nature; 1990 Dec; 348(6301):550-2. PubMed ID: 2147233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulating functions of tumor necrosis factor and interleukin 1 inhibitors.
    Dayer JM
    J Rheumatol Suppl; 1992 Jan; 32():59-60. PubMed ID: 1319488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.